| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.61▲ | 1.60▲ | 1.60▲ | 1.46▲ | 1.75▼ |
| MA10 | 1.59▲ | 1.53▲ | 1.53▲ | 1.52▲ | 1.99▼ |
| MA20 | 1.51▲ | 1.48▲ | 1.48▲ | 1.72▼ | 2.80▼ |
| MA50 | 1.54▲ | 1.63▲ | 1.66▼ | 2.10▼ | 2.26▼ |
| MA100 | 1.70▼ | 1.82▼ | 1.87▼ | 2.88▼ | 2.20▼ |
| MA200 | 1.89▼ | 2.11▼ | 2.39▼ | 2.75▼ | 11.27▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.021▲ | 0.035▲ | 0.037▲ | 0.012▲ | -0.216▼ |
| RSI | 67.067▲ | 61.911▲ | 60.483▲ | 41.238▼ | 36.784▼ |
| STOCH | 89.474▲ | 96.226▲ | 96.226▲ | 25.678 | 7.529▼ |
| WILL %R | -1.923▲ | -1.695▲ | -1.695▲ | -55.200 | -87.982▼ |
| CCI | 137.106▲ | 122.646▲ | 122.646▲ | -19.707 | -97.269 |
|
Tuesday, March 24, 2026 10:10 AM
NuCana Plc is a clinical stage biopharmaceutical company. It engages in the business of developing a portfolio of new medicines to treat patients with cancer. The company was founded by Hugh Stephen ...
|
|
Sunday, June 01, 2025 03:56 AM
Key data is currently not available. Data Disclaimer: The Nasdaq Indices and the Major Indices are delayed at least 1 minute. *Data is provided by Barchart.com. Data reflects weightings calculated at ...
|
|
Monday, September 16, 2024 02:24 AM
On Saturday, NuCana plc (NASDAQ:NCNA) presented final data from the Phase 2 NuTide:701 study at the ESMO Congress on NUC-7738 in combination with Merck & Co Inc's (NYSE:MRK) Keytruda (pembrolizumab) ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 02/04/26 | 1.54 | 1.6667 | 1.4233 | 1.63 | 18,089 |
| 01/04/26 | 1.41 | 1.59 | 1.41 | 1.54 | 28,931 |
| 31/03/26 | 1.45 | 1.45 | 1.39 | 1.40 | 43,297 |
| 30/03/26 | 1.42 | 1.50 | 1.3336 | 1.34 | 38,267 |
| 27/03/26 | 1.49 | 1.52 | 1.39 | 1.40 | 55,836 |
| 26/03/26 | 1.50 | 1.5373 | 1.48 | 1.48 | 21,886 |
| 25/03/26 | 1.55 | 1.5796 | 1.42 | 1.53 | 152,140 |
| 24/03/26 | 1.648 | 1.66 | 1.59 | 1.59 | 26,434 |
| 23/03/26 | 1.65 | 1.73 | 1.62 | 1.66 | 37,238 |
| 20/03/26 | 1.70 | 1.7472 | 1.63 | 1.65 | 46,163 |
|
|
||||
|
|
||||
|
|